The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital.

CEO Steven Gourlay, joins The Market Online to discuss the company’s development.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

acw by the numbers
More From The Market Online
The Market Online Video

Market Open: Fragile Iran war ceasefire to be week’s big topic; Hormuz reportedly closed again

At The Bell — Australian shares are wobbling slightly heading into Week 26, with the stuttering U.S.

Kaoko is hunting copper on Namibia’s quietest frontier. Now the drill bit has to talk

Most ASX juniors in mining take a while to get going, spending their early months settling…

Accelerate Resources kicks off follow-up drilling at Spencers gold discovery

Accelerate Resources is following-up the Spencers gold discovery with RC drilling underway within the Balagundi project…
The Market Online Video

HotCopper Highlights: 1414 Degrees, EOS and Novonix drive investor interest

1414 Degrees was one of the most viewed stocks on HotCopper this week, while EOS, Cynata,…